Portfolio company
Nanocept
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company combines nanotechnology and diagnostics to enable early disease detection and support clinical decision-making for healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
NANOLYZE
This company develops waveguide microscopy equipment for real-time analysis of nanoparticles to support researchers in drug development and nanomedicine.
Presymptom Health
This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Health Triage
This company develops artificial intelligence software for early cancer detection and clinical diagnosis to assist healthcare facilities and medical professionals.
Voc Diagnostics
This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.
ARTIDIS
This company develops a nanomechanical nanotechnology platform for cancer diagnosis and treatment optimisation, serving clinicians and researchers within healthcare systems.
